Use este identificador para citar ou linkar para este item:
http://sgc.anlis.gob.ar/handle/123456789/1414
Título: | Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes | Autor(es): | Albareda, María Cecilia Natale, María A De Rissio, Ana María Fernandez, Marisa Serjan, Alicia Alvarez, María G Cooley, Gretchen Shen, Huifeng Viotti, Rodolfo Bua, Jacqueline Castro Eiro, Melisa D Nuñez, Myriam Fichera, Laura E. Lococo, Bruno Scollo, Karenina Tarleton, Rick L Laucella, Susana A. |
Palavras-chave: | Linfocitos T;Trypanosoma cruzi;benznidazole;Nifurtimox;infección pediátrica | Data do documento: | 2018 | Jornal: | Frontiers in immunology | Resumo: | Background: In contrast to adults, Trypanosoma cruzi-infected children have more broadly functional Trypanosoma cruzi-specific T cells, and the total T-cell compartment exhibits fewer signs of immune exhaustion. However, not much is known about the link between immunocompetence and the treatment efficacy for human Chagas disease. Methods: Using cytokine enzyme-linked immunosorbent spot (ELISPOT) polychromatic flow cytometry, cytometric bead assay, multiplex serological assays and quantitative PCR, we evaluated T. cruzi-specific T-cell and antibody immune responses, T-cell phenotypes and parasitemia in children in the early chronic phase of Chagas disease undergoing anti-Trypanosoma cruzi treatment. Results: Treatment with benznidazole or nifurtimox induced a decline in T. cruzi-specific IFN-γ- and IL-2-producing cells and proinflammatory cytokines and chemokines. T-cell responses became detectable after therapy in children bearing T-cell responses under background levels prior to treatment. The total frequencies of effector, activated and antigen-experienced T cells also decreased following anti-T. cruzi therapy, along with an increase in T cells expressing the receptor of the homeostatic cytokine IL-7. Posttreatment changes in several of these markers distinguished children with a declining serologic response suggestive of successful treatment from those with sustained serological responses in a 5-year follow-up study. A multivariate analysis demonstrated that lower frequency of CD4+CD45RA-CCR7-CD62L- T cells prior to drug therapy was an independent indicator of successful treatment. Conclusions: These findings further validate the usefulness of alternative metrics to monitor treatment outcomes. Distinct qualitative and quantitative characteristics of T cells prior to drug therapy may be linked to treatment efficacy. |
URI: | http://sgc.anlis.gob.ar/handle/123456789/1414 | DOI: | 10.3389/fimmu.2018.01958 |
Aparece nas Coleções: | Publicaciones INP |
Arquivos neste item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
fimmu-09-01958.pdf | Artículo en inglés | 3.82 MB | Adobe PDF | Ver/Aberto |
Visualização de página
41
Checado em 19/04/2024
Download(s)
8
Checado em 19/04/2024
Google ScholarTM
Checar
Altmetric
Altmetric
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.